Prosecution Insights
Prosecution Insights
27 pending office actions • 21 art units • 27 examiners • 1 of 27 (4%) have an AI response strategy ready • 33 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 27 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 27 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (7%) |
| §103 only | 13 (48%) |
| §112 only | 3 (11%) |
| Double-patenting + other | 2 (7%) |
| No statute on record | 7 (26%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HEIN, DEVIN C | 1 | 45.8% | +29.9% |
| REICHERT, RACHELLE LEIGH | 1 | 30.3% | +34.0% |
| PETRASH, HILARY ANN | 1 | 63.8% | +51.7% |
| HABTE, KAHSAY | 1 | 84.9% | +7.3% |
| STAVROU, CONSTANTINA E | 1 | 44.2% | +31.4% |
| FETTEROLF, BRANDON J | 1 | 49.5% | +14.6% |
| SCHMIDT, IZABELA MARIA | 1 | 63.1% | +53.5% |
| LEE, SIN J | 1 | 68.8% | +25.5% |
| JACKSON, SHAWQUIA | 1 | 77.9% | -3.4% |
| BERKE-SCHLESSEL, DAVID W | 1 | 66.5% | +32.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17926235 | TUMOR MUTATIONAL BURDEN ASSOCIATED WITH SENSITIVITY TO IMMUNOTHERAPY IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA | AEDER, SEAN E | 124d overdue |
| 18855064 | PREDICTING DISEASE PROGRESSION IN PORTAL HYPERTENSION USING MACHINE LEARNING | REICHERT, RACHELLE LEIGH | 70d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18421142 | COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS | STAVROU, CONSTANTINA E | 45d overdue |
| 18855182 | PREDICTING ALBUMINURIA USING MACHINE LEARNING | HEIN, DEVIN C | 12d |
| 18564778 | METHODS OF TREATING BREAST CANCER | FETTEROLF, BRANDON J | 16d |
| 18550546 | SYSTEM AND METHOD FOR ONLINE DETECTION OF A POST-TRANSLATIONAL MODIFICATION OF A POLYPEPTIDE | BERKE-SCHLESSEL, DAVID W | 16d |
| 18552014 | FORMULATION COMPRISING CERALASERTIB | LEE, SIN J | 21d |
| 18492216 | METHODS OF TREATMENT OF BREAST CANCER | SCHMIDT, IZABELA MARIA | 26d |
| 18753316 | ANTIBODY MOLECULES AND CONJUGATES | PETRASH, HILARY ANN | 54d |
| 18855064 | PREDICTING DISEASE PROGRESSION IN PORTAL HYPERTENSION USING MACHINE LEARNING | REICHERT, RACHELLE LEIGH | 70d |
| Art Unit | Apps |
|---|---|
| 1626 | 3 |
| 3686 | 2 |
| 1625 | 2 |
| 1629 | 2 |
| 1642 | 2 |
| 1644 | 1 |
| 1624 | 1 |
| 1632 | 1 |
| 1621 | 1 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18855182 | PREDICTING ALBUMINURIA USING MACHINE LEARNING | HEIN, DEVIN C | 3686 | §103 | Non-Final OA | 12d | Pending | Oct 08, 2024 |
| 18855064 | PREDICTING DISEASE PROGRESSION IN PORTAL HYPERTENSION USING MACHINE LEARNING | REICHERT, RACHELLE LEIGH | 3686 | §101 | Non-Final OA | 70d | Pending | Oct 08, 2024 |
| 18753316 | ANTIBODY MOLECULES AND CONJUGATES | PETRASH, HILARY ANN | 1644 | Other | Non-Final OA | 54d | Pending | Jun 25, 2024 |
| 18443829 | SPIROCYCLIC COMPOUNDS | HABTE, KAHSAY | 1624 | Other | Non-Final OA | 12d | Pending | Feb 16, 2024 |
| 18421142 | COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS | STAVROU, CONSTANTINA E | 1632 | §112 | Non-Final OA | 45d overdue | Pending | Jan 24, 2024 |
| 18564778 | METHODS OF TREATING BREAST CANCER | FETTEROLF, BRANDON J | 1626 | §103 | Non-Final OA | 16d | Pending | Nov 28, 2023 |
| 18492216 | METHODS OF TREATMENT OF BREAST CANCER | SCHMIDT, IZABELA MARIA | 1621 | §103 | Non-Final OA | 26d | Pending | Oct 23, 2023 |
| 18552014 | FORMULATION COMPRISING CERALASERTIB | LEE, SIN J | 1613 | §103 | Final Rejection | 21d | Pending | Sep 22, 2023 |
| 18470548 | PCSK9 INHIBITORS AND METHODS OF USE THEREOF | JACKSON, SHAWQUIA | 1626 | — | Non-Final OA | 14d | Pending | Sep 20, 2023 |
| 18550546 | SYSTEM AND METHOD FOR ONLINE DETECTION OF A POST-TRANSLATIONAL MODIFICATION OF A POLYPEPTIDE | BERKE-SCHLESSEL, DAVID W | 1651 | §103 | Non-Final OA | 16d | Pending | Sep 14, 2023 |
| 18549852 | METHODS FOR TREATING SMALL CELL LUNG CANCER AND OTHER NEUROENDOCRINE CANCERS | CHANDRAKUMAR, NIZAL S | 1625 | DPOther | Non-Final OA | 62d | Pending | Sep 08, 2023 |
| 18452008 | PHARMACEUTICAL PROCESS AND INTERMEDIATES | OH, TAYLOR V | 1625 | §103 | Non-Final OA | 15d | Pending | Aug 18, 2023 |
| 18448559 | COMBINATION THERAPIES FOR TREATMENT OF CIRRHOSIS WITH PORTAL HYPERTENSION | REDWOOD, CHRISTOPHER EVAN | 1629 | §103 | Non-Final OA | 9d overdue | AI Ready | Aug 11, 2023 |
| 18262934 | CLINICAL ENDPOINT ADJUDICATION SYSTEM AND METHOD | PATEL, SHERYL GOPAL | 3685 | §103 | Final Rejection | 17d overdue | Pending | Jul 26, 2023 |
| 18257123 | N-(2-(4-CYANOTHIAZOLIDIN-3-YL)-2-OXOETHYL)-QUINOLINE-4-CARBOXAMIDES | ANDERSON, REBECCA L | 1626 | §112 | Final Rejection | 2d overdue | Pending | Jun 13, 2023 |
| 18253280 | STEROID SPARING | HADDAD, MAHER M | 1641 | Other | Non-Final OA | 77d overdue | Pending | May 17, 2023 |
| 18247014 | COMPOUNDS AND THEIR USE IN TREATING CANCER | TOWNSLEY, SARA ELIZABETH | 1629 | Other | Non-Final OA | 87d overdue | Pending | Mar 28, 2023 |
| 18177374 | BINDING MOLECULES AGAINST FRa | KAUFMAN, CLAIRE M | 1674 | DPOther | Non-Final OA | 60d | Pending | Mar 02, 2023 |
| 17926235 | TUMOR MUTATIONAL BURDEN ASSOCIATED WITH SENSITIVITY TO IMMUNOTHERAPY IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA | AEDER, SEAN E | 1642 | §101 | Non-Final OA | 124d overdue | Pending | Nov 18, 2022 |
| 17998275 | ATR INHIBITORS FOR THE TREATMENT OF CANCER | HIRAKIS, SOPHIA P | 1623 | Other | Non-Final OA | 10d overdue | Pending | Nov 09, 2022 |
| 18046173 | COMBINATION | REDDIG, PETER J | 1646 | §103 | Final Rejection | 43d overdue | Pending | Oct 13, 2022 |
| 17917333 | COMPOSITIONS AND METHODS FOR IMPROVED SITE-SPECIFIC MODIFICATION | ALLEN, SARAH ELIZABETH | 1637 | Other | Non-Final OA | 22d overdue | Pending | Oct 06, 2022 |
| 17772187 | DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINE | HAGHIGHATIAN, MINA | 1616 | §103 | Non-Final OA | 19d overdue | Pending | Apr 27, 2022 |
| 17754844 | MODULATORS OF PNPLA3 EXPRESSION | CHONG, KIMBERLY | 1636 | §112 | Non-Final OA | 69d | Pending | Apr 13, 2022 |
| 17765585 | METHODS AND COMBINATIONS FOR THE TREATMENT OF CANCER USING IMMUNE CHECKPOINT INHIBITOR ANTIBODIES | CHATTIN, AMY MARIE | 1643 | §103 | Non-Final OA | 15d overdue | Pending | Mar 31, 2022 |
| 17754258 | COMBINATION TREATMENT FOR CANCER | DARPOLOR, JOSEPHINE KEBBEH | 1642 | §103 | Non-Final OA | 119d overdue | Pending | Mar 29, 2022 |
| 17318017 | METHODS AND COMBINATIONS FOR THE TREATMENT OF CANCER USING IMMUNE CHECKPOINT INHIBITOR ANTIBODIES | BUTTICE, AUDREY L | 1647 | §103 | Final Rejection | 30d overdue | Pending | May 12, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial